Aug 11, 2026 03:35PM
Aug 11, 2026 03:35PM
Jul 29, 2026 07:10AM
Jul 29, 2026 07:10AM
Jul 20, 2026 04:05PM
Jul 20, 2026 04:05PM
May 22, 2026 11:30AM The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
Apr 20, 2026 04:30PM
Apr 20, 2026 04:30PM
Feb 24, 2026 07:00AM
Jan 13, 2026 06:34AM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Dec 12, 2025 06:21AM AxoGen, Inc. (AXGN) PT Raised to $40 at Leerink Partners
Dec 8, 2025 06:46AM
Dec 4, 2025 10:02AM
Dec 4, 2025 07:27AM
Dec 3, 2025 08:01PM
Dec 3, 2025 08:01PM
Oct 30, 2025 05:37AM
Oct 29, 2025 01:26PM AxoGen, Inc. (AXGN) PT Raised to $27 at Canaccord Genuity
Oct 29, 2025 07:00AM
Oct 1, 2025 01:20PM
Aug 25, 2025 11:01AM
Aug 25, 2025 06:40AM
Aug 25, 2025 06:40AM
Aug 11, 2025 07:05AM
Aug 5, 2025 07:00AM Axogen, Inc. Reports Second Quarter 2025 Financial Results
Jul 29, 2025 01:02PM
May 8, 2025 07:05AM
Feb 25, 2025 04:39PM
Feb 25, 2025 07:00AM
Nov 7, 2024 07:00AM
Sep 6, 2024 07:00AM
Sep 6, 2024 07:00AM Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
Aug 13, 2024 04:18PM
Aug 8, 2024 07:00AM
Jun 24, 2024 07:00AM
May 28, 2024 04:30PM
May 16, 2024 07:02AM
May 16, 2024 07:00AM
May 2, 2024 07:00AM Axogen, Inc Reports First Quarter 2024 Financial Results
Apr 29, 2024 04:50PM
Mar 5, 2024 07:00AM
Nov 7, 2023 07:00AM
Aug 7, 2023 04:01PM
May 9, 2023 07:00AM
May 4, 2022 04:01PM
May 4, 2022 04:01PM Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft
May 4, 2022 04:01PM

329,910 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All